FDA announces new steps to empower consumers and advance digital health care

FDA

27 July 2017 - When people think about personalised medicine, they often think of genetic testing and sequencing of the human genome. 

But the concept of personalised medicine is much broader. It includes the re-imagination of healthcare delivery. It includes empowering consumers to take more control of their own health care information to make better informed decisions about their medical care and healthy living.

This opportunity is enabled by a new technological paradigm of digital health tools, like apps, that enable consumers to have more active engagement and access to real-time information about their health and their activities. These tools allow consumers and providers to supersede the traditional, physical constraints of healthcare delivery and exploit the opportunities offered by mobile technology.

Read FDA blog

Michael Wonder

Posted by:

Michael Wonder